Summary
The product Injectable Superdrol 10mg, manufactured by Olympian Pharmaceutical, underwent independent testing to confirm its authenticity and potency. The sample, identified by batch number 0069, was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis detected the presence of Methasterone, with a measured concentration of 12.89 mg/ml, exceeding the labeled claim of 10 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 8 November 2024. While the results indicate the presence of Methasterone in a concentration higher than the stated dosage, continued scrutiny of manufacturer-submitted samples remains crucial to ensure consistency across batches. Independent third-party validation is recommended to further verify these findings. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Injectable Superdrol 10mg
- Active Ingredient: Methasterone
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51791
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification: 10 mg/ml (as stated on the label)
- Measured Concentration: 12.89 mg/ml
- Accuracy: 128.9% (28.9% above the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51791_LDIZF7SNKK1Z
Evaluation of Manufacturer-Submitted Testing
This analysis reveals that Injectable Superdrol 10mg contains a higher concentration of Methasterone than labeled, raising concerns about accurate dosing. As Olympian Pharmaceutical submitted and funded this test, independent third-party verification is advised to ensure batch consistency and consumer safety. While Janoshik Analytical is known for transparency and rigorous testing, additional analyses from neutral sources would strengthen confidence in these results.
Conclusion
The findings confirm that Injectable Superdrol 10mg is overdosed, with a measured concentration of 12.89 mg/ml, exceeding the expected 10 mg/ml. Although this batch maintains a higher active ingredient concentration, the deviation from the labeled amount emphasizes the need for continued testing to ensure dosing accuracy across multiple batches. This report is provided as an educational resource to promote harm reduction and informed decision-making.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it still provides useful data when critically assessed alongside third-party or independent results. Readers are encouraged to interpret this information responsibly.
